BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Diagnosis
43 results:

  • 1. [Bone Marrow Carcinomatosis with Disseminated Intravascular Coagulation in a Breast cancer Patient Treated with Chemotherapy and cdk4/6 Inhibitor].
    Kume S; Makino T; Goto A; Onodera Y; Kudo S
    Gan To Kagaku Ryoho; 2023 Dec; 50(12):1331-1333. PubMed ID: 38247075
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Integrated analysis and validation of the TRIM28-H2AX-cdk4 diagnostic model assists to predict the progression of HCC.
    Tian Q; Lu G; Ma Y; Ma L; Shang Y; Guo N; Huang Y; Zhu L; Du R
    Aging (Albany NY); 2023 Oct; 15(24):14617-14650. PubMed ID: 37870748
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Incidence and Features of Lymphoid Proliferation and Lymphomas after Solid Organ or Hematopoietic Stem Cell Transplantation in a National Database Cohort.
    Hahn SM; Lee M; Hyun J; Lim S; Kang JM; Ahn JG; Joo DJ; Jung I; Ihn K
    Cancer Res Treat; 2024 Jan; 56(1):305-313. PubMed ID: 37475137
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors.
    Rao X; Chen Y; Beyrer J; Nash Smyth E; Morato Guimaraes C; Litchfield LM; Bowman L; Lawrence GW; Aggarwal A; Andre F
    Clin Cancer Res; 2023 Sep; 29(17):3372-3383. PubMed ID: 37289194
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and Evaluation of Crocetin-Functionalized Pegylated Magnetite Nanoparticles for Hepatocellular Carcinoma.
    Ibrahim S; Baig B; Hisaindee S; Darwish H; Abdel-Ghany A; El-Maghraby H; Amin A; Greish Y
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049645
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diagnostic Performance of the 2018 EASL vs. LI-RADS for Hepatocellular Carcinoma Using CT and MRI: A Systematic Review and Meta-Analysis of Comparative Studies.
    Shin J; Lee S; Yoon JK; Roh YH
    J Magn Reson Imaging; 2023 Dec; 58(6):1942-1950. PubMed ID: 37010244
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma.
    Jiang C; Liu Z; Yuan J; Wu Z; Kong L; Yang J; Lv T
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901767
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Eight Cases of Breast cancer That Relapsed More Than Ten Years after Initial Treatment].
    Yoshimura A; Ueda T; Tanaka T; Kirihataya Y; Soga M; Yokotani T
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1935-1937. PubMed ID: 36733049
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
    Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
    J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.
    Liu S; Zheng Q; Zhang R; Li T; Zhan J
    Pediatr Surg Int; 2022 Dec; 38(12):2023-2034. PubMed ID: 36271952
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Simplified LI-RADS for Hepatocellular Carcinoma diagnosis at Gadoxetic Acid-enhanced MRI.
    Kwag M; Choi SH; Choi SJ; Byun JH; Won HJ; Shin YM
    Radiology; 2022 Dec; 305(3):614-622. PubMed ID: 35972362
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
    Wang Y; Zhang Y; Mi J; Jiang C; Wang Q; Li X; Zhao M; Geng Z; Song X; Li J; Zuo L; Ge S; Zhang Z; Wen H; Wang Z; Su F
    Oncogene; 2022 Jul; 41(29):3680-3693. PubMed ID: 35725908
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?
    Xie S; Zhang Y; Chen J; Jiang T; Liu W; Rong D; Sun L; Zhang L; He B; Wang J
    Abdom Radiol (NY); 2022 Feb; 47(2):596-607. PubMed ID: 34773467
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
    J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
    Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
    J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.
    Zhang Y; Tang W; Xie S; Chen J; Zhang L; Rong D; Kuang S; He B; Wang J
    Eur Radiol; 2021 Oct; 31(10):7715-7724. PubMed ID: 33782766
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinicopathologic findings of chronic active Epstein-Barr virus infection in adults: A single-center retrospective study in China.
    Lin J; Wu H; Gu L; Wu X; Su M; Lin H; Liu B; Zheng J; Mei X; Li D
    Clin Exp Med; 2021 Aug; 21(3):369-377. PubMed ID: 33635476
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic cancer Metabolism Biomarker of Hepatocellular Carcinoma.
    Ong JR; Bamodu OA; Khang NV; Lin YK; Yeh CT; Lee WH; Cherng YG
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477333
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools.
    Gerratana L; Davis AA; Polano M; Zhang Q; Shah AN; Lin C; Basile D; Toffoli G; Wehbe F; Puglisi F; Behdad A; Platanias LC; Gradishar WJ; Cristofanilli M
    Eur J Cancer; 2021 Jan; 143():147-157. PubMed ID: 33307492
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increasing the sensitivity of LI-RADS v2018 for diagnosis of small (10-19 mm) HCC on extracellular contrast-enhanced MRI.
    Chen J; Kuang S; Zhang Y; Tang W; Xie S; Zhang L; Rong D; He B; Deng Y; Xiao Y; Shi W; Fowler K; Wang J; Sirlin CB
    Abdom Radiol (NY); 2021 Apr; 46(4):1530-1542. PubMed ID: 33040166
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.